Business StandardCenter·
Sun Pharma down 2%, stock hits over 5-month low
Thus far in the calendar year 2026, Sun Pharma outperformed the market and remained flat, as compared to a 14.7% decline in the BSE Sensex.
Read at Business Standard →
Business · 1 sources covering this
Sun Pharma down 2%, stock hits over 5-month low
Thus far in the calendar year 2026, Sun Pharma outperformed the market and remained flat, as compared to a 14.7% decline in the BSE Sensex.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/e6de20d0614fdc03c68400e4a1ff612f33ec396d" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Sun Pharma down 2%, stock hits over 5-month low"></iframe>
